 San Diego, California--Newsfile Corp. - June 6, 2022 - Skye Bioscience, Inc. OTCQB: SKYE Skye or the Company, a pharmaceutical company developing proprietary, synthetic cannabinoid derivatives to treat glaucoma and other diseases with significant unmet need, announced today that it will be presenting a corporate overview at the LD Micro 12th Annual Invitational being held in-person at the Four Seasons Westlake Village, California, June 7-9, 2022.Punit Dhillon, Chief Executive Officer and Chair, will present on... 